Ventana Biotech Inc
Ventana Global Inc. provides various portfolio of loans. The company offers custom financial, borrower and lender network, business advising and mentoring, and cash flow services. It also provides consulting services to third party businesses and individuals. The company was formerly known as Ventana Biotech, Inc. and changed its name to Ventana Global Inc. in January 2015. Ventana Global Inc. is… Read more
Ventana Biotech Inc (VNTA) - Total Liabilities
Latest total liabilities as of January 2025: $115.02K USD
Based on the latest financial reports, Ventana Biotech Inc (VNTA) has total liabilities worth $115.02K USD as of January 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ventana Biotech Inc - Total Liabilities Trend (2008–2025)
This chart illustrates how Ventana Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Ventana Biotech Inc Competitors by Total Liabilities
The table below lists competitors of Ventana Biotech Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ZHONG AN REIT
BE:35Z
|
Germany | €35.61 Billion |
|
European Assets Trust PLC
LSE:EAT
|
UK | GBX36.05 Million |
|
National Reinsurance Corporation of the Philippines
PSE:NRCP
|
Philippines | ₱13.21 Billion |
|
BRAZILIAN METAL
BE:LR4
|
Germany | €171.69K |
|
Golden Prospect Precious Metals Ltd
LSE:GPM
|
UK | GBX3.68 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Ventana Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.88 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ventana Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ventana Biotech Inc (2008–2025)
The table below shows the annual total liabilities of Ventana Biotech Inc from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-04-30 | $114.34K | +7.74% |
| 2024-04-30 | $106.13K | -25.47% |
| 2009-04-30 | $142.39K | +255.82% |
| 2008-04-30 | $40.02K | -- |